A Portable Magnetic Particle Spectrometer for Future Rapid and Wash-Free Bioassays

Nowadays, there is an increasing demand for more accessible routine diagnostics for patients with respect to high accuracy, ease of use, and low cost. However, the quantitative and high accuracy bioassays in large hospitals and laboratories usually require trained technicians and equipment that is b...

Full description

Saved in:
Bibliographic Details
Published inACS applied materials & interfaces Vol. 13; no. 7; pp. 7966 - 7976
Main Authors Wu, Kai, Chugh, Vinit Kumar, di Girolamo, Arturo, Liu, Jinming, Saha, Renata, Su, Diqing, Krishna, Venkatramana D, Nair, Abilash, Davies, Will, Wang, Yongqiang Andrew, Cheeran, Maxim C-J, Wang, Jian-Ping
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 24.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nowadays, there is an increasing demand for more accessible routine diagnostics for patients with respect to high accuracy, ease of use, and low cost. However, the quantitative and high accuracy bioassays in large hospitals and laboratories usually require trained technicians and equipment that is both bulky and expensive. In addition, the multistep bioassays and long turnaround time could severely affect the disease surveillance and control especially in pandemics such as influenza and COVID-19. In view of this, a portable, quantitative bioassay device will be valuable in regions with scarce medical resources and help relieve burden on local healthcare systems. Herein, we introduce the MagiCoil diagnostic device, an inexpensive, portable, quantitative, and rapid bioassay platform based on the magnetic particle spectrometer (MPS) technique. MPS detects the dynamic magnetic responses of magnetic nanoparticles (MNPs) and uses the harmonics from oscillating MNPs as metrics for sensitive and quantitative bioassays. This device does not require trained technicians to operate and employs a fully automatic, one-step, and wash-free assay with a user friendly smartphone interface. Using a streptavidin-biotin binding system as a model, we show that the detection limit of the current portable device for streptavidin is 64 nM (equal to 5.12 pmole). In addition, this MPS technique is very versatile and allows for the detection of different diseases just by changing the surface modifications on MNPs. Although MPS-based bioassays show high sensitivities as reported in many literatures, at the current stage, this portable device faces insufficient sensitivity and needs further improvements. It is foreseen that this kind of portable device can transform the multistep, laboratory-based bioassays to one-step field testing in nonclinical settings such as schools, homes, offices, etc.
Bibliography:Author Contributions
K.W. and V.K.C. have contributed equally to this work.
ISSN:1944-8244
1944-8252
DOI:10.1021/acsami.0c21040